RxDoctor Payments Data

Amandeep Singh

Gastroenterology · Cleveland, OHNPI 1841509874

Payments from drug & device makers

What this record shows

This record is dominated by grants: $100,000 of the $112,838 with a category attached, or 88.6%. 30 manufacturers reported payments, led by Cook Incorporated at 35.4% of the total. Reporting peaked in 2022 at $56,528 and has fallen 98.1% since, to $1,081 in 2025. Among gastroenterology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$112,838in general payments, 2019–2025

Across 116 payments — averaging $972.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cook Incorporated$40K
  • Cook Medical LLC$40K
  • Boston Scientific$24K
  • Boehringer Ingelheim$4K
  • Intercept Pharmaceuticals, Inc.$3K
  • AbbVie$628
  • plus $2K from 24 others

What the payments were for

  • Speaking & faculty fees$6,4216%
  • Grants$100,00089%
  • Travel & lodging$2,3812%
  • Food & beverage$3,8033%
  • Education$2340%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$112,838 in reported general payments places this provider in the 90th percentile of 657 gastroenterology providers in Ohio.

See all gastroenterology providers in Ohio →

Medicare billing

Part B allowed, 2024
$42,870
Medicare patients
193
Services billed
314

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl30$358
Omeprazole39$235
Pantoprazole Sodium30$171

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Cleveland

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →